Related Experiment Video
Updated: Jun 27, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
QSAR models for 2-amino-6-arylsulfonylbenzonitriles and congeners HIV-1 reverse transcriptase inhibitors based on
Rongjing Hu1, Jean-Pierre Doucet, Michel Delamar
1Department of Chemistry, Lanzhou University, Lanzhou, Gansu 730000, PR China.
Abstract:
A quantitative structure-activity relationship study of a series of HIV-1 reverse transcriptase inhibitors (2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners) was performed. Topological and geometrical, as well as quantum mechanical energy-related and charge distribution-related descriptors generated from CODESSA, were selected to describe the molecules. Principal component analysis (PCA) was used to select the training set. Six techniques: multiple linear regression (MLR), multivariate adaptive regression splines (MARS), radial basis function neural networks (RBFNN), general regression neural networks (GRNN), projection pursuit regression (PPR) and support vector machine (SVM) were used to establish QSAR models for two data sets: anti-HIV-1 activity and HIV-1 reverse transcriptase binding affinity. Results showed that PPR and SVM models provided powerful capacity of prediction.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Quantitative Aspects of Drug-Receptor Interaction
Pharmacodynamic Models: Linear Concentration–Effect Model

